Background illustration for clinical trials search

Paid Clinical Trials Fort Collins

Discover 1,271 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population

for
Kidney Injury
Location: Denver CO, Boston MA
Sponsor: BioPorto Diagnostics

Sex: All

Age: 18+

Code: NCT03057457

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Denver CO, Salt Lake City UT, Calgary, Newport Beach CA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Westwood KS, Gilbert AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Denver CO, Salt Lake City UT, Kansas City KS, Tucson AZ,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: Denver CO, Sarasota FL, New York NY
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT05463263

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Tucson AZ, Minneapolis MN, Tyler TX,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Denver CO, Duarte CA, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase1, Phase2, Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Duarte CA, Milwaukee WI, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase1, Recruiting

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

for
Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer,
Location: Denver CO, Los Angeles CA, Nashville TN
Sponsor: RasCal Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04678648

Phase1, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Denver CO, Aurora CO, Saint Louis MO, Houston TX,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase1, Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT04910568

Phase1, Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma (MM), Multiple Myeloma Refractory,
Location: Denver CO, Las Vegas NV, Eugene OR, Nashville TN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07637578

Phase2, Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Denver CO, Atlanta GA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06768489

Phase1, Recruiting

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

for
Lymphoma, Non-Hodgkin, Lymphoma, Follicular,
Location: Denver CO, Nashville TN, Toronto
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07519772

Phase1, Phase2, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Santa Fe NM, Salt Lake City UT, Omaha NE,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Denver CO, Scottsdale AZ, Rochester MN, Dallas TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase1, Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for
Relapsed or Refractory Large B-cell Lymphoma
Location: Denver CO, Goodyear AZ, St Louis MO, Austin TX,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT07479797

Phase3, Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Denver CO, Houston TX, Grand Rapids MI, Nashville TN,
Sponsor: Prelude Therapeutics Incorporated

Sex: All

Age: 18+

Code: NCT07469891

Phase1, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Kansas City KS, Waukee IA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Phoenix AZ, Iowa City IA,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting